HansBiomed Corporation (KOSDAQ:042520)
South Korea
· Delayed Price · Currency is KRW 44,250
-6,450 (-12.72%)
At close: Mar 9, 2026
HansBiomed Ratios and Metrics
Market cap in millions KRW. Fiscal year is October - September.
Millions KRW. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Market Capitalization | 607,198 | 235,973 | 127,792 | 207,570 | 92,964 | 160,691 | Upgrade
|
| Market Cap Growth | 456.60% | 84.65% | -38.43% | 123.28% | -42.15% | -29.01% | Upgrade
|
| Enterprise Value | 634,436 | 268,360 | 153,787 | 241,607 | 132,643 | 187,080 | Upgrade
|
| Last Close Price | 44250.00 | 18170.00 | 9840.00 | 17930.00 | 9610.00 | 16050.00 | Upgrade
|
| PE Ratio | - | - | - | - | 15.12 | - | Upgrade
|
| Forward PE | 41.66 | 6.95 | 6.95 | 6.95 | 6.95 | 6.95 | Upgrade
|
| PS Ratio | 6.06 | 2.63 | 1.58 | 2.66 | 1.25 | 2.72 | Upgrade
|
| PB Ratio | 8.56 | 6.96 | 1.90 | 4.16 | 1.96 | 3.38 | Upgrade
|
| P/TBV Ratio | 8.62 | 7.11 | 1.93 | 4.29 | 2.08 | 3.70 | Upgrade
|
| P/OCF Ratio | - | 741.27 | 72.67 | - | - | - | Upgrade
|
| EV/Sales Ratio | 6.33 | 2.99 | 1.90 | 3.10 | 1.78 | 3.17 | Upgrade
|
| EV/EBITDA Ratio | - | - | 25.58 | 231.57 | 21.54 | - | Upgrade
|
| EV/EBIT Ratio | - | - | 245.82 | - | 105.60 | - | Upgrade
|
| EV/FCF Ratio | -24.55 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.61 | 1.28 | 0.54 | 0.82 | 1.18 | 1.08 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 6.06 | 39.43 | 9.08 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.38 | 1.04 | 0.44 | 0.68 | 0.89 | 0.66 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.34 | -1.54 | 4.85 | 32.68 | 6.88 | -2.09 | Upgrade
|
| Net Debt / FCF Ratio | -1.05 | -22.77 | -34.90 | -6.01 | -5.13 | -1.60 | Upgrade
|
| Asset Turnover | 0.77 | 0.72 | 0.67 | 0.61 | 0.57 | 0.45 | Upgrade
|
| Inventory Turnover | 1.39 | 1.34 | 1.05 | 1.20 | 1.26 | 1.64 | Upgrade
|
| Quick Ratio | 0.60 | 0.31 | 0.38 | 0.31 | 0.32 | 0.49 | Upgrade
|
| Current Ratio | 1.16 | 0.69 | 0.99 | 0.77 | 0.73 | 0.84 | Upgrade
|
| Return on Equity (ROE) | -41.69% | -63.51% | -13.33% | -49.47% | 10.36% | -37.86% | Upgrade
|
| Return on Assets (ROA) | -12.16% | -14.05% | 0.32% | -2.04% | 0.60% | -9.46% | Upgrade
|
| Return on Invested Capital (ROIC) | -30.27% | -33.74% | 0.69% | -4.78% | 1.49% | -25.01% | Upgrade
|
| Return on Capital Employed (ROCE) | -31.50% | -61.50% | 0.90% | -7.30% | 2.20% | -28.90% | Upgrade
|
| Earnings Yield | -4.52% | -13.28% | -5.65% | -11.10% | 6.61% | -11.38% | Upgrade
|
| FCF Yield | -4.26% | -0.65% | -0.65% | -2.73% | -8.88% | -12.16% | Upgrade
|
| Buyback Yield / Dilution | -0.90% | -0.29% | -20.83% | 18.41% | -31.21% | -1.48% | Upgrade
|
| Total Shareholder Return | -0.90% | -0.29% | -20.83% | 18.41% | -31.21% | -1.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.